drugset / Trial / NCT04149860
Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease
RandomizedSequentialDouble-blindTreatment
Summary
The purpose of this study is to investigate the safety of a single dose of Lu AF87908, how well it is tolerated and what the body does to the drug in healthy participants and participants with Alzheimer's disease.
Timeline
- Start
- 2019-09-27
- Primary completion
- 2023-07-19
- Completion
- 2023-07-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lu AF87908 | Unknown | — | Intravenous |